文献速递胃肠动力与功能性疾病

车前子可减少IBS患者菊粉诱导的结肠产气:MRI与体外发酵研究

Psyllium reduces inulin-induced colonic gas production in IBS: MRI and in vitro fermentation studies.
PubMed 文献 · Gut · 2021-08-05

该随机、四周期、四治疗、安慰剂对照交叉试验纳入19例IBS患者,比较菊粉20g、车前子20g、菊粉20g+车前子20g或葡萄糖20g安慰剂后结肠产气情况。主要终点为MRI评估的结肠气体,结果显示菊粉产气最多,联用车前子可显著降低菊粉相关产气,且体外发酵中车前子并未直接抑制发酵。

要点

  • 车前子与菊粉联用可显著降低IBS患者菊粉诱导的结肠产气。
  • 车前子并不直接抑制体外发酵产气,提示其作用非通过抑制发酵。
  • 联用车前子能否提高IBS患者对益生元的耐受性尚需进一步研究。

核心结论

  • 在IBS患者中,车前子可减少菊粉相关的结肠产气,但不直接抑制发酵。

研究设计与样本

  • 随机、四周期、四治疗、安慰剂对照交叉试验,纳入19例IBS患者。
  • 受试者摄入含菊粉20g、车前子20g、菊粉20g+车前子20g或葡萄糖20g安慰剂的500mL测试饮料。
  • 每30分钟测呼气氢,每小时行MRI扫描共6小时,部分患者粪便行体外发酵模型测试。

主要发现

  • 结肠气体从0至6小时稳步上升,菊粉引起最大上升,中位(IQR)AUC(0-360 min)为3145(848-6502)mL·min。
  • 菊粉与车前子联用后AUC(0-360 min)显著降至618(62-2345)mL·min(p=0.02),与安慰剂无显著差异。
  • 结肠体积AUC(0-360 min)在菊粉(p=0.002)及菊粉+车前子(p=0.005)均显著大于安慰剂。
  • 呼气氢在菊粉后120分钟起显著上升,车前子无此作用;联用延迟并降低最大升幅,AUC(0-360 min)从7230(3255-17910)ppm·hour降至1035(360-4320)ppm·hour(p=0.007)。
  • 体外发酵中菊粉产气多于车前子,但车前子与菊粉联用并未减少产气。

临床怎么用

  • 对于因菊粉等益生元出现腹胀产气的IBS患者,可考虑联用车前子以改善产气相关症状。
  • 车前子的作用可能并非通过直接抑制发酵,临床解释时应避免过度归因于发酵抑制。

局限性

  • 研究样本量较小(19例IBS患者)。
  • 体外发酵仅使用部分患者粪便样本,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Health-promoting dietary fibre including inulin often triggers gastrointestinal symptoms in patients with IBS, limiting their intake. Our aim was to test if coadministering psyllium with inulin would reduce gas production. DESIGN: A randomised, four-period, four-treatment, placebo-controlled, crossover trial in 19 patients with IBS. Subjects ingested a 500 mL test drink containing either inulin 20 g, psyllium 20 g, inulin 20 g+ psyllium 20 g or dextrose 20 g (placebo). Breath hydrogen was measured every 30 min with MRI scans hourly for 6 hours. Faecal samples from a subset of the patients with IBS were tested using an in vitro fermentation model. Primary endpoint was colonic gas assessed by MRI. RESULTS: Colonic gas rose steadily from 0 to 6 hours, with inulin causing the greatest rise, median (IQR) AUC(0-360 min) 3145 (848-6502) mL·min. This was significantly reduced with inulin and psyllium coadministration to 618 (62-2345) mL·min (p=0.02), not significantly different from placebo. Colonic volumes AUC(0-360 min) were significantly larger than placebo for both inulin (p=0.002) and inulin and psyllium coadministration (p=0.005). Breath hydrogen rose significantly from 120 min after inulin but not psyllium; coadministration of psyllium with inulin delayed and reduced the maximum increase, AUC(0-360 min) from 7230 (3255-17910) ppm·hour to 1035 (360-4320) ppm·hour, p=0.007.Fermentation in vitro produced more gas with inulin than psyllium. Combining psyllium with inulin did not reduce gas production. CONCLUSIONS: Psyllium reduced inulin-related gas production in patients with IBS but does not directly inhibit fermentation. Whether coadministration with psyllium increases the tolerability of prebiotics in IBS warrants further study. TRIAL REGISTRATION NUMBER: NCT03265002.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Gunn D, Abbas Z, Harris HC, et al. Psyllium reduces inulin-induced colonic gas production in IBS: MRI and in vitro fermentation studies. Gut. 2021. PMID: 34353864. doi:10.1136/gutjnl-2021-324784

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。